A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate. |
| Hydrocodone | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate. |
| Magnesium sulfate | The therapeutic efficacy of Methadyl acetate can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Methadyl acetate may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate. |
| Orphenadrine | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate. |
| Pramipexole | Methadyl acetate may increase the sedative activities of Pramipexole. |
| Ropinirole | Methadyl acetate may increase the sedative activities of Ropinirole. |
| Rotigotine | Methadyl acetate may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Methadyl acetate. |
| Sodium oxybate | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate. |
| Thalidomide | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Alvimopan | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Alvimopan. |
| Desmopressin | The risk or severity of hyponatremia can be increased when Methadyl acetate is combined with Desmopressin. |
| Morphine | The risk or severity of adverse effects can be increased when Morphine is combined with Methadyl acetate. |
| Codeine | The risk or severity of adverse effects can be increased when Codeine is combined with Methadyl acetate. |
| Hydromorphone | The risk or severity of adverse effects can be increased when Hydromorphone is combined with Methadyl acetate. |
| Meperidine | The risk or severity of adverse effects can be increased when Meperidine is combined with Methadyl acetate. |
| Oxycodone | The risk or severity of adverse effects can be increased when Oxycodone is combined with Methadyl acetate. |
| Dextropropoxyphene | The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Methadyl acetate. |
| Naltrexone | The therapeutic efficacy of Methadyl acetate can be decreased when used in combination with Naltrexone. |
| Sufentanil | The risk or severity of adverse effects can be increased when Sufentanil is combined with Methadyl acetate. |
| Alfentanil | The risk or severity of adverse effects can be increased when Alfentanil is combined with Methadyl acetate. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Methadyl acetate. |
| Levorphanol | The risk or severity of adverse effects can be increased when Levorphanol is combined with Methadyl acetate. |
| Remifentanil | The risk or severity of adverse effects can be increased when Remifentanil is combined with Methadyl acetate. |
| Diphenoxylate | The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Methadyl acetate. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Oxymorphone is combined with Methadyl acetate. |
| Dezocine | The risk or severity of adverse effects can be increased when Dezocine is combined with Methadyl acetate. |
| Dihydroetorphine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Dihydroetorphine. |
| Diamorphine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Diamorphine. |
| Bezitramide | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Bezitramide. |
| Ethylmorphine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Ethylmorphine. |
| Etorphine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Etorphine. |
| Dextromoramide | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Dextromoramide. |
| Desomorphine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Desomorphine. |
| Carfentanil | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Carfentanil. |
| Dihydrocodeine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Dihydrocodeine. |
| Alphacetylmethadol | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Alphacetylmethadol. |
| Dihydromorphine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Dihydromorphine. |
| Ketobemidone | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Ketobemidone. |
| DPDPE | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with DPDPE. |
| Lofentanil | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Lofentanil. |
| Opium | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Opium. |
| Normethadone | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Normethadone. |
| Piritramide | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Piritramide. |
| Alphaprodine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Alphaprodine. |
| Nicomorphine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Nicomorphine. |
| Meptazinol | The therapeutic efficacy of Methadyl acetate can be decreased when used in combination with Meptazinol. |
| Phenoperidine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Phenoperidine. |
| Phenazocine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Phenazocine. |
| Tilidine | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Tilidine. |
| Carfentanil, C-11 | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Carfentanil, C-11. |
| Naloxegol | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Naloxegol. |
| Benzhydrocodone | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Benzhydrocodone. |
| Pegvisomant | The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Methadyl acetate. |
| Succinylcholine | The risk or severity of bradycardia can be increased when Succinylcholine is combined with Methadyl acetate. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Methadyl acetate. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Methadyl acetate. |
| Mirtazapine | Methadyl acetate may increase the serotonergic activities of Mirtazapine. |
| Fluvoxamine | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Fluvoxamine. |
| Citalopram | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Citalopram. |
| Duloxetine | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Duloxetine. |
| Paroxetine | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Paroxetine. |
| Sertraline | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Sertraline. |
| Sibutramine | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Sibutramine. |
| Nefazodone | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Nefazodone. |
| Zimelidine | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Zimelidine. |
| Dapoxetine | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Dapoxetine. |
| Milnacipran | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Methadyl acetate. |
| Seproxetine | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Seproxetine. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Levomilnacipran. |
| Indalpine | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Indalpine. |
| Ritanserin | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Ritanserin. |
| Alaproclate | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Alaproclate. |
| Ethanol | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Methadyl acetate may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Methadyl acetate. |
| Phentermine | Phentermine may increase the analgesic activities of Methadyl acetate. |
| Pseudoephedrine | Pseudoephedrine may increase the analgesic activities of Methadyl acetate. |
| Benzphetamine | Benzphetamine may increase the analgesic activities of Methadyl acetate. |
| Diethylpropion | Diethylpropion may increase the analgesic activities of Methadyl acetate. |
| Lisdexamfetamine | The risk or severity of serotonin syndrome can be increased when Methadyl acetate is combined with Lisdexamfetamine. |
| Mephentermine | Mephentermine may increase the analgesic activities of Methadyl acetate. |
| MMDA | MMDA may increase the analgesic activities of Methadyl acetate. |
| Midomafetamine | Midomafetamine may increase the analgesic activities of Methadyl acetate. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may increase the analgesic activities of Methadyl acetate. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may increase the analgesic activities of Methadyl acetate. |